Osteoporosis Most Recent
MD, CCFP, BSc.N
Osteoporosis affects approximately 2 million Canadians…
MD, FRCSC
In spite of great effort, low back pain (LBP) remains a significant burden on society and one of the most common reasons to see a primary care provider.
MD, FRCSC
In 1987, the Quebec Taskforce noted, "Distinct patterns of reliable clinical findings are the only logical basis for back pain categorization and subsequent treatment."
MD, FRCSC
Back dominant pain is either intensified by flexion or is not aggravated by bending forward.
MD, FRCSC
Leg dominant pain suggests direct nerve root involvement: radicular, not referred symptoms.
Dans sa présentation au groupe de conférenciers qui discuterait de nouvelles perspectives de traitement de l’ostéoporose, la Dre Angela Juby, nouvelle présidente de la Société canadienne de gériatrie, a premièrement encouragé l’auditoire à réfléchir à la définition de l’ostéoporose.
Advertisement
La Dre Alexandra Papaioannou a passé en revue les résultats d’essais de phase 3 sur le dénosumab qu’elle a décrit comme un « nouveau produit passionnant » qui fait l’objet de recherches.
Dr. Earl Bogoch’s key message concerned the importance of identifying and treating osteoporosis after a fragility fracture, in order to prevent future fractures, most importantly of the hip.
Advances in the understanding of bone biology and the role of the RANK/RANKL/OPG pathway have opened new treatment avenues for osteoporosis.
In her introduction to a panel of speakers discussing new horizons in the treatment of osteoporosis, incoming Canadian Geriatrics Society President Dr. Angela Juby first encouraged listeners to recall the definition of osteoporosis.
